Comparative Study of Neoadjuvant Chemotherapy With and Without Zometa for Management of Locally Advanced Breast Cancers

Trial Profile

Comparative Study of Neoadjuvant Chemotherapy With and Without Zometa for Management of Locally Advanced Breast Cancers

Discontinued
Phase of Trial: Phase II

Latest Information Update: 12 Dec 2015

At a glance

  • Drugs Zoledronic acid (Primary) ; Cyclophosphamide; Docetaxel; Doxorubicin
  • Indications Breast cancer
  • Focus Therapeutic Use
  • Acronyms NEOZOL
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 12 Dec 2015 Status changed from completed to discontinued according to results presented at the 38th Annual San Antonio Breast Cancer Symposium.
    • 12 Dec 2015 Results presented at the 38th Annual San Antonio Breast Cancer Symposium
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top